Editas Medicine
EDIT
#8290
Rank
ยฃ0.17 B
Marketcap
ยฃ1.82
Share price
-0.41%
Change (1 day)
8.14%
Change (1 year)

Revenue for Editas Medicine (EDIT)

Revenue in 2025 (TTM): ยฃ36.2 Million

According to Editas Medicine 's latest financial reports the company's current revenue (TTM ) is ยฃ34.79 Million. In 2024 the company made a revenue of ยฃ25.74 Million a decrease over the revenue in the year 2023 that were of ยฃ61.32 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Editas Medicine from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ36.2 M40.62%
2024 ยฃ25.74 M-58.01%
2023 ยฃ61.32 M276.37%
2022 ยฃ16.29 M-13.9%
2021 ยฃ18.92 M-71.57%
2020 ยฃ66.56 M325.14%
2019 ยฃ15.65 M-37.77%
2018 ยฃ25.15 M147.7%
2017 ยฃ10.15 M107.06%
2016 ยฃ4.9 M346.26%
2015 ยฃ1.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
ยฃ0.48 B 1,284.71% Jersey
Novavax
NVAX
ยฃ0.76 B 2,108.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
ยฃ0.1 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
ยฃ16.38 M-52.92%๐Ÿ‡ฌ๐Ÿ‡ง UK